TGF-β1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation

Immunology

Volumn 126, Issue 4, 2009, Pages 485-499

  Ohtani, Tomoyuki ^a   Mizuashi, Masato ^a   Nakagawa, Satoshi ^a   Sasaki, Yoshinori ^a   Fujimura, Taku ^a   Okuyama, Ryuhei ^a   Aiba, Setsuya ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antigen presenting cells; Apoptosis; Costimulatory molecules; Dendritic cells; Langerhans cells

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ADENOSINE TRIPHOSPHATE; CD86 ANTIGEN; HAPTEN; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 1BETA; LANGERIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; T6 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; CD34 ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL FUNCTION; CELL LINE; CELL MATURATION; CELL PROTECTION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENVIRONMENT; ENZYME ACTIVATION; EPIDERMIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; KERATINOCYTE; LANGERHANS CELL; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT DURATION; ULTRAVIOLET RADIATION; CELL CULTURE; CELL DIFFERENTIATION; DOSE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; NECROSIS; PATHOLOGY;

ADENOSINE TRIPHOSPHATE; ANTIGENS, CD34; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DINITROCHLOROBENZENE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HAPTENS; HUMANS; IMMUNE TOLERANCE; KERATINOCYTES; LANGERHANS CELLS; NECROSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TRANSFORMING GROWTH FACTOR BETA1; ULTRAVIOLET RAYS;

EID: 61449211195     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02919.x     Document Type: Article

References (47)

1. Borkowski TA, Letterio JJ, Mackall CL, Saitoh A, Wang XJ, Roop DR, Gress RE, Udey MC. A role for TGF beta1 in Langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGF beta 1 null mice. J Clin Invest 1997 100 : 575 81.
2. + hematopoietic progenitors. J Immunol 1996 157 : 1499 507.
3. Riedl E, Strobl H, Majdic O, Knapp W. TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J Immunol 1997 158 : 1591 7.
4. Strobl H, Bello-Fernandez C, Riedl E, Pickl WF, Majdic O, Lyman SD, Knapp W. Flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 1997 90 : 1425 34.
5. + progenitors. J Leukocyte Biol 1999 66 : 781 91.
6. + hematopoietic progenitor cells into Langerhans cells under serum-free conditions without GM-CSF. J Invest Dermatol 2003 120 : 256 65.
7. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. Transforming growth factor beta 1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998 187 : 961 6.
8. Geissmann F, Revy P, Regnault A et al. TGF-beta1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 1999 162 : 4567 75.
9. Sato K, Kawasaki H, Nagayama H, Enomoto M, Morimoto C, Tadokoro K, Juji T, Takahashi TA. TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors. J Immunol 2000 164 : 2285 95.
10. Fogel-Petrovic M, Long JA, Misso NL, Foster PS, Bhoola KD, Thompson PJ. Physiological concentrations of transforming growth factor beta1 selectively inhibit human dendritic cell function. Int Immunopharmacol 2007 7 : 1924 33.
11. Mizumoto N, Kumamoto T, Robson SC, Sevigny J, Matsue H, Enjyoji K, Takashima A. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 2002 8 : 358 65.
12. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988 106 : 761 71.
13. + precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. J Immunol 1999 163 : 4869 77.
14. + cells differentiate into dermal dendritic cells in co-culture with cutaneous fibroblasts or stromal cells. J Invest Dermatol 2002 118 : 450 60.
15. Manome H, Aiba S, Tagami H. Simple chemicals can induce maturation and apoptosis of dendritic cells. Immunology 1999 98 : 481 90.
16. Aiba S, Manome H, Nakagawa S, Mollah ZU, Mizuashi M, Ohtani T, Yoshino Y, Tagami H. p38 mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and DNCB. J Invest Dermatol 2003 120 : 390 8.
17. Anonymous. User Bulletin #2. ABI PRISM 7700 Sequence Detection System, PE Applied Biosystems : Faster City, CA, 1997.
18. Relloso M, Puig-Kroger A, Pello OM et al. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J Immunol 2002 168 : 2634 43.
19. Bechetoille N, Andre V, Valladeau J, Perrier E, Dezutter-Dambuyant C. Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli. J Leukocyte Biol 2006 80 : 45 58.
20. Aiba S, Terunuma A, Manome H, Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol 1997 27 : 3031 8.
21. Schnurr M, Then F, Galambos P, Scholz C, Siegmund B, Endres S, Eigler A. Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J Immunol 2000 165 : 4704 9.
22. la Sala A, Ferrari D, Corinti S, Cavani A, Di Virgilio F, Girolomoni G. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J Immunol 2001 166 : 1611 7.
23. Nakagawa S, Ohtani T, Mizuashi M, Mollah ZU, Ito Y, Tagami H, Aiba S. p38 mitogen-activated protein kinase mediates dual role of ultraviolet B radiation in induction of maturation and apoptosis of monocyte-derived dendritic cells. J Invest Dermatol 2004 123 : 361 70.
24. Coutinho-Silva R, Persechini PM, Bisaggio RD et al. P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am J Physiol 1999 276 : C1139 47.
25. Nihei OK, de Carvalho AC, Savino W, Alves LA. Pharmacologic properties of P(2Z)/P2X(7)receptor characterized in murine dendritic cells: role on the induction of apoptosis. Blood 2000 96 : 996 1005.
26. Aiba S, Katz SI. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J Immunol 1990 145 : 2791 6.
27. Ozawa H, Nakagawa S, Tagami H, Aiba S. Interleukin-1 beta and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J Invest Dermatol 1996 106 : 441 5.
28. Aiba S, Manome H, Yoshino Y, Tagami H. In vitro treatment of human TGF-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 2000 101 : 68 75.
29. Coutant KD, de Fraissinette AB, Cordier A, Ulrich P. Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicol Sci 1999 52 : 189 98.
30. Tuschl H, Kovac R, Weber E. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicol In Vitro 2000 14 : 541 9.
31. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 2001 166 : 3837 45.
32. + -derived DC by NiCl(2) and SDS. Toxicol In Vitro 2001 15 : 319 25.
33. Boisleve F, Kerdine-Romer S, Rougier-Larzat N, Pallardy M. Nickel and DNCB induce CCR7 expression on human dendritic cells through different signaling pathways: role of TNF-alpha and MAPK. J Invest Dermatol 2004 123 : 494 502.
34. Staquet MJ, Sportouch M, Jacquet C, Schmitt D, Guesnet J, Peguet-Navarro J. Moderate skin sensitizers can induce phenotypic changes on in vitro generated dendritic cells. Toxicol In Vitro 2004 18 : 493 500.
35. Mizumoto N, Mummert ME, Shalhevet D, Takashima A. Keratinocyte ATP release assay for testing skin-irritating potentials of structurally diverse chemicals. J Invest Dermatol 2003 121 : 1066 72.
36. Jacobson KA, Mamedova L, Joshi BV, Besada P, Costanzi S. Molecular recognition at adenine nucleotide (P2) receptors in platelets. Semin Thromb Hemost 2005 31 : 205 16.
37. Jorgl A, Platzer B, Taschner S, Heinz LX, Hocher B, Reisner PM, Gobel F, Strobl H. Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB. Blood 2007 109 : 185 93.
38. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001 13 : 114 9.
39. Ardeshna KM, Pizzey AR, Devereux S, Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000 96 : 1039 46.
40. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003 21 : 685 711.
41. Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, Steinman RM. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002 196 : 1091 7.
42. Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001 194 : 769 79.
43. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 2000 1 : 305 10.
44. Kissenpfennig A, Henri S, Dubois B et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005 22 : 643 54.
45. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML, Clausen BE. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005 169 : 569 76.
46. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005 23 : 611 20.
47. Bennett CL, Noordegraaf M, Martina CA, Clausen BE. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J Immunol 2007 179 : 6830 5.